Economy

Government relaxes manufacturing standards for specific medicine types under Schedule M regulations

Originally reported by TripuraTimes.com as: Govt eases Schedule M norms for select drug categories

19 Nov 2026, 1:49 pm IST · Xecute.finance News DeskArchive edition

The crisp read

The central government has relaxed Schedule M manufacturing norms for selected categories of pharmaceutical products. This regulatory adjustment aims to simplify compliance for certain drug producers while maintaining quality oversight. Industry participants are evaluating the revised requirements to understand their operational impact.

Xecute Impact Breakdown

For CAs

  • Review the revised standards to verify client eligibility for the relaxed provisions.
  • Update operational risk assessments and compliance checklists to reflect the regulatory adjustments for manufacturing clients.

For businesses

  • Examine the updated Schedule M manufacturing norms for select drug categories to identify potential compliance adjustments.
  • Verify specific category exemptions immediately to optimize regulatory alignment.

Deep dive – the full story

The central administration has officially relaxed Schedule M manufacturing norms specifically for select drug categories. This regulatory update modifies compliance obligations for targeted pharmaceutical manufacturers operating within the designated product segments. Schedule M establishes the good manufacturing practices (GMP) and requirements for premises and plant equipment for pharmaceutical products.

Historically, these standardized benchmarks applied broadly across the manufacturing sector, often creating procedural hurdles for smaller or specialized producers. By easing these norms for specific categories, regulators aim to reduce compliance friction while attempting to preserve essential quality and safety baselines. Pharmaceutical manufacturers and their compliance consultants must carefully examine the revised standards to verify eligibility for the relaxed provisions.

Tax professionals and auditors should update their operational risk assessments and compliance checklists to reflect these regulatory adjustments. Bottom line: Verify specific category exemptions immediately to optimize your manufacturing clients' regulatory alignment.

Source: news.google.com

This is news/educational content, not investment advice. Xecute.finance is not SEBI-registered. Consult a qualified professional before acting.

More from the Xecute news desk

Reading the archive edition.

This story has retired from the live feed - the full text stays here permanently. The live app adds the newest desk, Ask Xecute, deadline trackers and the daily quiz.

Open this story in the Xecute app →